Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Livia Goldraich"'
Autor:
Livia Goldraich, Peter C. Austin, Limei Zhou, Jack V. Tu, Michael J. Schull, Susanna Mak, Heather J. Ross, David A. Morrow, Douglas S. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 7 (2016)
BackgroundPatients with heart failure (HF) presenting to the emergency department (ED) can be admitted to care settings of different intensity, where the intensive care unit (ICU) is the highest intensity, ward admission is intermediate intensity, an
Externí odkaz:
https://doaj.org/article/574cc5e65d024678aa8854fedcc10790
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 94, Iss 3, Pp 385-393 (2010)
FUNDAMENTO: Identificação e impacto clínico da fração de ejeção preservada em desfechos intra-hospitalares em pacientes com insuficiência cardíaca (IC) descompensada permanecem pouco conhecidos. OBJETIVO: Descrever preditores clínicos e des
Externí odkaz:
https://doaj.org/article/eb0c78dc63bd48798deb156f5ce56b35
Autor:
Mike Walker, Michael McDonald, Livia Goldraich, Juarez R. Braga, Farid Foroutan, Heather J. Ross
Publikováno v:
Journal of Cardiac Failure. 23:422-426
Background Chronotropic incompetence (CI) in heart failure (HF) patients with cardiac resynchronization therapy (CRT) and activity sensors may vary according to exercise modality. We hypothesized that chronotropic response and exercise capacity diffe
Autor:
Vivek Rao, Livia Goldraich, P. Billia, Heather J. Ross, William E. Stansfield, Farid Foroutan, Juarez R. Braga, Jimmy Misurka, Terrence M. Yau, Hiroyuki Kawajiri
Publikováno v:
Journal of Cardiac Surgery. 31:110-116
BACKGROUND Tricuspid annular (TA) dilation has been suggested as a more reliable marker of concomitant advanced right ventricular failure (RVF) than severity of tricuspid regurgitation (TR). Our objective was to examine the impact of TA dilation on o
Autor:
Michael J. Schull, Douglas S. Lee, Limei Zhou, Peter C. Austin, Heather J. Ross, David A. Morrow, Jack V. Tu, Susanna Mak, Livia Goldraich
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patients with heart failure ( HF ) presenting to the emergency department ( ED ) can be admitted to care settings of different intensity, where the intensive care unit ( ICU ) is the highest intensity, ward admission is intermediate intens
Autor:
Livia, Goldraich, Hiroyuki, Kawajiri, Farid, Foroutan, Juarez, Braga, Phyllis, Billia, Jimmy, Misurka, William E, Stansfield, Terrence, Yau, Heather J, Ross, Vivek, Rao
Publikováno v:
Journal of cardiac surgery. 31(2)
Tricuspid annular (TA) dilation has been suggested as a more reliable marker of concomitant advanced right ventricular failure (RVF) than severity of tricuspid regurgitation (TR). Our objective was to examine the impact of TA dilation on occurrence o
Autor:
H.J. Ross, Mosaad Alhussein, Yasbanoo Moayedi, Farid Foroutan, Livia Goldraich, Ana C. Alba, A.I. Dipchand, J.G. Duero Posada, S. Fan, Jennifer A. McCaughan, K. Runeckles, C. Manhliot, S. Kozuszko, Kathryn Tinckam
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S107
Autor:
Julieta Lazarte, Livia Goldraich, Cedric Manlhiot, Hiroyuki Kawajiri, Liza Grosman-Rimon, Arash Ghashghai, Vivek Rao, Diego Delgado
Publikováno v:
Circulation. 132
Introduction: Human Leukocyte Antigen (HLA)-G is an immune inhibitor molecule that has been shown to inhibit smooth muscle cell proliferation in vitro and promote vasculature protection against cardiac allograft vasculopathy (CAV). Single polymorphis
Autor:
Vivek Rao, Julieta Lazarte, Livia Goldraich, Diego H. Delgado, Cedric Manlhiot, Stella Kozuszko
Publikováno v:
Human immunology. 77(9)
Background Post transplantation, a major complication is the development of malignancies. Human Leukocyte Antigen (HLA)-G is a molecule that inhibits the immune system and it is utilized by malignant cells to hide from the immune system. Expression o
Autor:
Filio Billia, Cedric Manlhiot, Heather J. Ross, Vivek Rao, Julieta Lazarte, Livia Goldraich, Diego H. Delgado
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 35(9)
Background In heart transplant recipients, human leukocyte antigen G (HLA-G) has been shown to inhibit endothelial and smooth muscle cells injury in vitro, suggesting protection against cardiac allograft vasculopathy (CAV). Although the expression of